feed,title,long_url,short_url
Benzinga,JNJ's Rybrevant Scores FDA Approval In Lung Cancer Patients With EGFR Exon 20 Mutation,https://benzinga.com/general/biotech/21/05/21239641/jnjs-rybrevant-scores-fda-approval-in-lung-cancer-patients-with-egfr-exon-20-mutation,https://j.mp/3oF9AsU
